Cargando…
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220150/ https://www.ncbi.nlm.nih.gov/pubmed/27884018 http://dx.doi.org/10.1038/bjc.2016.386 |
_version_ | 1782492573098573824 |
---|---|
author | Welsh, Liam Panek, Rafal Riddell, Angela Wong, Kee Leach, Martin O Tavassoli, Mahvash Rahman, Durdana Schmidt, Maria Hurley, Tara Grove, Lorna Richards, Thomas Koh, Dow-Mu Nutting, Christopher Harrington, Kevin Newbold, Kate Bhide, Shreerang |
author_facet | Welsh, Liam Panek, Rafal Riddell, Angela Wong, Kee Leach, Martin O Tavassoli, Mahvash Rahman, Durdana Schmidt, Maria Hurley, Tara Grove, Lorna Richards, Thomas Koh, Dow-Mu Nutting, Christopher Harrington, Kevin Newbold, Kate Bhide, Shreerang |
author_sort | Welsh, Liam |
collection | PubMed |
description | BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is likely to be a significant oversimplification given the fact that tumour hypoxia is the result of several intrinsic and extrinsic factors, including many that are not directly related to serum haemoglobin (Hb). Therefore, we have studied the effect of PRCT on tumour oxygenation in a prospective cohort of patients who developed low Hb during radical CRT for HNSCC. METHODS: This was a prospective study of 20 patients with HNSCC receiving radical CRT undergoing PRCT for Hb<11.5 g dl(−1). Patients underwent pretransfusion and posttransfusion intrinsic susceptibility-weighted (SWI) MRI and dynamic contrast-enhanced (DCE) MRI. Blood samples were obtained at the time of MRI scanning and two further time points for measuring Hb and a panel of serum cytokine markers of tumour hypoxia. 3D T(2)* and K(trans) maps were calculated from the MRI data for primary tumours and cervical lymph node metastases. RESULTS: PRCT produced no change (11 patients) or reduced (1 patient) T(2)* (tumour oxygenation) in 12 of the 16 (75%) evaluable primary tumours. Three of the four patients with improved tumour oxygenation progressed or had partial response following treatment completion. There were variable changes in K(trans) (tumour perfusion or vessel permeability) following PRCT that were of small magnitude for most tumours. Pre- and Post-PRCT levels of measured cytokines were not significantly different. CONCLUSIONS: This study suggests that PRCT during radical CRT for HNSCC does not improve tumour oxygenation. Therefore, oncologists should consider changing practice according to NICE and American Association of Blood Banks guidelines on PRCT for anaemia. |
format | Online Article Text |
id | pubmed-5220150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52201502018-01-03 Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck Welsh, Liam Panek, Rafal Riddell, Angela Wong, Kee Leach, Martin O Tavassoli, Mahvash Rahman, Durdana Schmidt, Maria Hurley, Tara Grove, Lorna Richards, Thomas Koh, Dow-Mu Nutting, Christopher Harrington, Kevin Newbold, Kate Bhide, Shreerang Br J Cancer Clinical Study BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is likely to be a significant oversimplification given the fact that tumour hypoxia is the result of several intrinsic and extrinsic factors, including many that are not directly related to serum haemoglobin (Hb). Therefore, we have studied the effect of PRCT on tumour oxygenation in a prospective cohort of patients who developed low Hb during radical CRT for HNSCC. METHODS: This was a prospective study of 20 patients with HNSCC receiving radical CRT undergoing PRCT for Hb<11.5 g dl(−1). Patients underwent pretransfusion and posttransfusion intrinsic susceptibility-weighted (SWI) MRI and dynamic contrast-enhanced (DCE) MRI. Blood samples were obtained at the time of MRI scanning and two further time points for measuring Hb and a panel of serum cytokine markers of tumour hypoxia. 3D T(2)* and K(trans) maps were calculated from the MRI data for primary tumours and cervical lymph node metastases. RESULTS: PRCT produced no change (11 patients) or reduced (1 patient) T(2)* (tumour oxygenation) in 12 of the 16 (75%) evaluable primary tumours. Three of the four patients with improved tumour oxygenation progressed or had partial response following treatment completion. There were variable changes in K(trans) (tumour perfusion or vessel permeability) following PRCT that were of small magnitude for most tumours. Pre- and Post-PRCT levels of measured cytokines were not significantly different. CONCLUSIONS: This study suggests that PRCT during radical CRT for HNSCC does not improve tumour oxygenation. Therefore, oncologists should consider changing practice according to NICE and American Association of Blood Banks guidelines on PRCT for anaemia. Nature Publishing Group 2017-01-03 2016-11-24 /pmc/articles/PMC5220150/ /pubmed/27884018 http://dx.doi.org/10.1038/bjc.2016.386 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Clinical Study Welsh, Liam Panek, Rafal Riddell, Angela Wong, Kee Leach, Martin O Tavassoli, Mahvash Rahman, Durdana Schmidt, Maria Hurley, Tara Grove, Lorna Richards, Thomas Koh, Dow-Mu Nutting, Christopher Harrington, Kevin Newbold, Kate Bhide, Shreerang Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title | Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title_full | Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title_fullStr | Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title_full_unstemmed | Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title_short | Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
title_sort | blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220150/ https://www.ncbi.nlm.nih.gov/pubmed/27884018 http://dx.doi.org/10.1038/bjc.2016.386 |
work_keys_str_mv | AT welshliam bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT panekrafal bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT riddellangela bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT wongkee bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT leachmartino bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT tavassolimahvash bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT rahmandurdana bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT schmidtmaria bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT hurleytara bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT grovelorna bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT richardsthomas bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT kohdowmu bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT nuttingchristopher bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT harringtonkevin bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT newboldkate bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck AT bhideshreerang bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck |